Prunaretty J, Boisselier P, Riou O, Simeon S, Bedos L, Azria D, Fenoglietto P Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison. Rep Pract Oncol Radiother. 2019;24(1):97-104. doi:10.1016/j.rpor.2018.11.003
Combes E, Andrade A, Tosi D, Michaud H-A, Coquel F, Desigaud D, Jarlier M, Coquelle A, Pasero P, Bonnefoy N, Martineau P, Del Rio M, Beijersbergen R, Vezzio-Vie N Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) overcomes oxaliplatin resistance and promotes anti-tumor immunity in colorectal cancer. Cancer Res.. Apr 15, 2019. doi:10.1158/0008-5472.CAN-18-2807
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz L, Roger P, Guiu S, Derocq D, Robin G, Michaud H-A, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget J-P, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. J Immunother Cancer. 2019;7(1):29. doi:10.1186/s40425-019-0498-z
Perrot I, Michaud H-A, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Jecko D, Becquart O, Rispaud-Blanc H, Gauthier L, Rossi B, Chanteux S, Gourdin N, Amigues B, Roussel A, Bensussan A, Eliaou J-F, Bastid J, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E, Paturel C, Bonnefoy N Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies. Cell Rep. 2019;27(8):2411-2425.e9. doi:10.1016/j.celrep.2019.04.091
Groeneveld S, Faget J, Zangger N, Meylan E Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells. Oncotarget. 2018;9(64):32331-32345. doi:10.18632/oncotarget.25965
Faget J, Contat C, Zangger N, Peters S, Meylan E RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung Adenocarcinoma. J Thorac Oncol. 2018;13(3):387-398. doi:10.1016/j.jtho.2017.11.121
Lauche O, Castan F, de Forges H, Guillaumon C, Gourgou S, Fenoglietto P, Azria D, Riou O Prospective medical analysis of radiation therapist image repositioning during image-guided radiotherapy. Cancer Radiother. 2018;22(1):25-30. doi:10.1016/j.canrad.2017.07.048
Jacqueline C, Bonnefoy N, Charrière G, Thomas F, Roche B Personal history of infections and immunotherapy: Unexpected links and possible therapeutic opportunities. Oncoimmunology. 2018;7(8):e1466019. doi:10.1080/2162402X.2018.1466019
Durand M, Dubois F, Dejou C, Durand E, Danger R, Chesneau M, Brosseau C, Guerif P, Soulillou J-P, Degauque N, Eliaou J-F, Giral M, Bonnefoy N, Brouard S Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance. Kidney Int.. 2018;93(5):1154-1164. doi:10.1016/j.kint.2017.12.004
Bourgier C, Castan F, Riou O, Nguyen T-D, Peignaux K, Lemanski C, Lagrange J-L, Kirova Y, Lartigau E, Belkacemi Y, Rivera S, Noël G, Clippe S, Mornex F, Hennequin C, Gourgou S, Brengues M, Fenoglietto P, Ozsahin E, Azria D Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial. Oncotarget. 2018;9(21):15757-15765. doi:10.18632/oncotarget.24606
Kalambaden P, Faget J, Rusakiewicz S, Montay-Gruel P, Meylan E, Bourhis J, Lesec G, Vozenin M-C Cellular Composition and Contribution of Tertiary Lymphoid Structures to Tumor Immune Infiltration and Modulation by Radiation Therapy. Front Oncol. 2018;8. doi:10.3389/fonc.2018.00256
Lafont V, Michaud H-A, Bonnefoy N CD73: a new biomarker in triple-negative breast cancer. 2018;7(S5):S594-S596. doi:10.21037/tcr.2018.05.22
Gourdin N, Bossennec M, Rodriguez C, Vigano S, Machon C, Jandus C, Bauché D, Faget J, Durand I, Chopin N, Tredan O, Marie J, Dubois B, Guitton J, Romero P, Caux C, Ménétrier-Caux C Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints. Cancer Res.. 2018;78(13):3604-3618. doi:10.1158/0008-5472.CAN-17-2405
Riou O, Azria D, Mornex F [Stereotactic body radiotherapy for liver tumors: State of the art]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. Sep 06 2017. doi:10.1016/j.canrad.2017.07.040
Laprevotte E, Cochaud S, du Manoir S, Lapierre M, Dejou C, Philippe M, Giustiniani J, Frewer K, Sanders A, Jiang W, Michaud H-A, Colombo P-E, Bensussan A, Alberici G, Bastid J, Eliaou J-F, Bonnefoy N The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway. Oncotarget. 2017;8(69):113360-113372. doi:10.18632/oncotarget.23008
Riou O, Llacer Moscardo C, Fenoglietto P, Deshayes E, Tetreau R, Molinier J, Lenglet A, Assenat E, Ychou M, Guiu B, Bedos L, Azria D SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques. Rep Pract Oncol Radiother. 2017;22(2):103-110. doi:10.1016/j.rpor.2017.02.006
They L, Michaud H-A, Becquart O, Lafont V, Guillot B, Boissière-Michot F, Jarlier M, Mollevi C, Eliaou J-F, Bonnefoy N, Gros L PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody. Oncoimmunology. 2017;6(10):e1353857. doi:10.1080/2162402X.2017.1353857
Engblom C, Pfirschke C, Zilionis R, Da Silva Martins J, Bos S, Courties G, Rickelt S, Severe N, Baryawno N, Faget J, Savova V, Zemmour D, Kline J, Siwicki M, Garris C, Pucci F, Liao H-W, Lin Y-J, Newton A, Yaghi O, Iwamoto Y, Tricot B, Wojtkiewicz G, Nahrendorf M, Cortez-Retamozo V, Meylan E, Hynes R, Demay M, Klein A, Bredella M, Scadden D, Weissleder R, Pittet M Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science. 2017;358(6367). doi:10.1126/science.aal5081
Faget J, Groeneveld S, Boivin G, Sankar M, Zangger N, Garcia M, Guex N, Zlobec I, Steiner L, Piersigilli A, Xenarios I, Meylan E Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer. Cell Rep. 2017;21(11):3190-3204. doi:10.1016/j.celrep.2017.11.052
Llacer-Moscardo C, Riou O, Azria D, Bedos L, Ailleres N, Rouanet P, Ychou M, Fenoglietto P Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results. Rep Pract Oncol Radiother. 2017;22(2):141-149. doi:10.1016/j.rpor.2016.06.004
Barjon C, Michaud H-A, Fages A, Dejou C, Zampieri A, They L, Gennetier A, Sanchez F, Gros L, Eliaou J-F, Bonnefoy N, Lafont V IL-21 promotes the development of a CD73-positive V?9V?2 T cell regulatory population. Oncoimmunology. 2017;7(1):e1379642. doi:10.1080/2162402X.2017.1379642
Llacer C, Riou O, Deshayes E Evaluation of response after SBRT for liver tumors. Rep Pract Oncol Radiother. 2017;22(2):170-175. doi:10.1016/j.rpor.2015.12.004
Bedos L, Riou O, Braccini A, Molinier J, Moscardo C, Azria D, Fenoglietto P Evaluation of reproducibility of tumor repositioning during multiple breathing cycles for liver stereotactic body radiotherapy treatment. Rep Pract Oncol Radiother. 2017;22(2):132-140. doi:10.1016/j.rpor.2016.07.007
de Mulder M, SenGupta D, Deeks S, Martin J, Pilcher C, Hecht F, Sacha J, Nixon D, Michaud H Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers. Retrovirology. 2017;14. doi:10.1186/s12977-017-0365-2
Lapierre A, Riou O, Fléchon A, Mottet N, Azria D Advanced penile cancer with iliac lymph node involvement treated with radiation and concurrent gemcitabine. Cancer Radiother. 2017;21(2):134-137. doi:10.1016/j.canrad.2016.10.003
Institut de Recherche en Cancérologie de
